Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle-derived IL-7 and IL-15 are crucial for maintaining skin-resident memory T cells and could be targeted for treating skin diseases and lymphoma.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

Cutaneous epitheliotropic lymphoma in dogs is often misdiagnosed but can be treated with chemotherapy and alternative therapies.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

The document concludes that early recognition and treatment of primary cicatricial alopecia is crucial to prevent permanent hair loss.

The combination of mitoxantrone, etoposide, and prednisolone is effective for treating relapsed lymphoma with manageable side effects.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A woman with scalp lymphoma and hair loss improved with radiotherapy, highlighting the need for biopsies in similar cases.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Lymphoid-specific helicase (Lsh) is crucial for skin growth, change, and healing after injury.

Mouse models help target specific genes in lymphatic cells for research.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Understanding patients' views on their illness can help improve their disease management.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.

Children with frequent severe infections and low antibodies should be checked for immune deficiencies.

Hormone-replacement therapy improved a woman's skin condition known as lymphomatoid papulosis.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

CVP therapy showed moderate success in treating advanced non-Hodgkin's lymphoma, but more intensive treatment is needed for better outcomes.

Anti-CD19 therapy may help treat SLE and NMOSD.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

A new patch can deliver stable antibodies over time for potential HIV treatment.

A boy with severe immune deficiency and Epstein-Barr virus died from high-grade B-cell lymphoma.

ILC1-like cells can cause alopecia areata by affecting hair follicles.

Injecting anti-herpes antibodies locally can prevent skin lesions and sweating problems caused by herpes simplex virus in mice.

CD4+ lymphocytopenia can occur in patients with systemic lupus erythematosus.

Stopping methotrexate might reverse lymphoma-like conditions in some patients.

Bendamustine combined with rituximab is an effective and well-tolerated treatment for certain types of lymphoma.